Does TECLISTAMAB-CQYV Cause Lymphopenia? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Lymphopenia have been filed in association with TECLISTAMAB-CQYV. This represents 0.4% of all adverse event reports for TECLISTAMAB-CQYV.
6
Reports of Lymphopenia with TECLISTAMAB-CQYV
0.4%
of all TECLISTAMAB-CQYV reports
1
Deaths
4
Hospitalizations
How Dangerous Is Lymphopenia From TECLISTAMAB-CQYV?
Of the 6 reports, 1 (16.7%) resulted in death, 4 (66.7%) required hospitalization, and 1 (16.7%) were considered life-threatening.
Is Lymphopenia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TECLISTAMAB-CQYV. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does TECLISTAMAB-CQYV Cause?
Cytokine release syndrome (406)
Immune effector cell-associated neurotoxicity syndrome (153)
Off label use (122)
Death (116)
Plasma cell myeloma (96)
Infection (83)
Neutropenia (74)
Fatigue (72)
Pyrexia (67)
Covid-19 (64)
What Other Drugs Cause Lymphopenia?
FINGOLIMOD (1,515)
CYCLOPHOSPHAMIDE (952)
RITUXIMAB (932)
DEXAMETHASONE (814)
PREDNISONE (788)
DIMETHYL (598)
METHOTREXATE (549)
PREDNISOLONE (465)
TACROLIMUS (456)
MYCOPHENOLATE MOFETIL (453)
Which TECLISTAMAB-CQYV Alternatives Have Lower Lymphopenia Risk?
TECLISTAMAB-CQYV vs TEDIZOLID
TECLISTAMAB-CQYV vs TEDUGLUTIDE
TECLISTAMAB-CQYV vs TEDUGLUTIDE\WATER
TECLISTAMAB-CQYV vs TEGAFUR
TECLISTAMAB-CQYV vs TEGAFUR\URACIL